Imam Ghazali = " Apakah yang paling dekat dengan diri kita di dunia ini?
Murid 1 = " Orang tua "
Murid 2 = " Guru "
Murid 3 = " Teman "
Murid 4 = " Kaum kerabat "
Imam Ghazali = "Semua jawapan itu benar. Tetapi yang paling dekatdengan kita ialah MATI.
Sebab itu janji Allah bahawa setiap yangbernyawa pasti akan mati ( Surah Ali-Imran :185).
Imam Ghazali = " Apa yang paling jauh dari kita di dunia ini ?"
Murid 1 = " Negeri Cina "
Murid 2 = " Bulan "
Murid 3 = " Matahari "
Murid 4 = " Bintang-bintang "
Iman Ghazali = " Semua jawaban itu benar. Tetapi yang paling benaradalah MASA LALU.
Bagaimanapun kita, apapun kenderaan kita, tetap kitatidak akan dapat kembali ke masa yang lalu. Oleh sebab itu kita harusmenjaga hari ini, hari esok dan hari-hari yang akan datang denganperbuatan yang sesuai dengan ajaran Agama".
Iman Ghazali = " Apa yang paling besar didunia ini ?"
Murid 1 = " Gunung "
Murid 2 = " Matahari "
Murid 3 = " Bumi "
Imam Ghazali = " Semua jawaban itu benar, tapi yang besar sekali adalahHAWA NAFSU (Surah Al A'raf: 179).
Maka kita harus hati-hati dengan nafsukita, jangan sampai nafsu kita membawa ke neraka."
IMAM GHAZALI" Apa yang paling berat didunia? "
Murid 1 = " Baja "
Murid 2 = " Besi "
Murid 3 = " Gajah "
Imam Ghazali = " Semua itu benar, tapi yang paling berat adalah MEMEGANGAMANAH (Surah Al-Azab : 72 ).
Tumbuh-tumbuhan, binatang, gunung, danmalaikat semua tidak mampu ketika Allah SWT meminta mereka menjadikhalifah pemimpin) di dunia ini. Tetapi manusia dengan sombongnyaberebut-rebut menyanggupi permintaan Allah SWT sehingga banyak manusiamasuk ke neraka kerana gagal memegang amanah."
Imam Ghazali = " Apa yang paling ringan di dunia ini ?"
Murid 1 = " Kapas"
Murid 2 = " Angin "
Murid 3 = " Debu "
Murid 4 = " Daun-daun"
Imam Ghazali = " Semua jawaban kamu itu benar, tapi yang paling ringansekali didunia ini adalah MENINGGALKAN SOLAT. Gara-gara pekerjaan kitaatau urusan dunia, kita tinggalkan solat "
Imam Ghazali = " Apa yang paling tajam sekali di dunia ini? "
Murid- Murid dengan serentak menjawab = " Pedang "
Imam Ghazali = " Itu benar, tapi yang paling tajam sekali didunia iniadalah LIDAH MANUSIA. Kerana melalui lidah, manusia dengan mudahnyamenyakiti hati dan melukai perasaan saudaranya sendiri "
Sumber :http://www.ukhuwah.or.id
Wednesday, June 11, 2008
Hal yang Paling ..... di Dunia
What Is Psoriasis?
Psoriasis is a chronic (long-lasting) skin disease characterized by scaling and inflammation. Scaling occurs when cells in the outer layer of skin reproduce faster than normal and pile up on the skin's surface.
Psoriasis affects 2 to 2.6 percent of the United States population, or almost 5.8 to 7 million people. It occurs in all age groups and about equally in men and women. People with psoriasis may suffer discomfort, restricted motion of joints, and emotional distress.
When psoriasis develops, patches of skin thicken, redden, and become covered with silvery scales. These patches are sometimes referred to as plaques. They may itch or burn. The skin at joints may crack. Psoriasis most often occurs on the elbows, knees, scalp, lower back, face, palms, and soles of the feet. The disease also may affect the fingernails, toenails, and the soft tissues inside the mouth and genitalia. About 10 percent of people with psoriasis have joint inflammation that produces symptoms of arthritis. This condition is called psoriatic arthritis.
Psoriasis is not contagious in any way. It is not possible to "catch" psoriasis by touching a person afflicted with it.
Drug Works Well for Moderate-to-Severe Psoriasis
THURSDAY, May 15 (HealthDay News) -- The drug ustekinumab has been shown to be a very effective initial and long-term treatment for moderate-to-severe psoriasis in two studies published in this week's issue of The Lancet.
Ustekinumab works by binding to two interleukins, proteins produced by the immune system that mediate inflammatory reactions in diseases like psoriasis. The binding stops the interleukins from reaching their specific receptors on the surface of cells.
"Not only does ustekinumab compare favorably to the best available therapies for psoriasis, the maintenance of response between injections every three months also provides a more convenient regimen than those currently available," Drs. Brenda Bartlett and Stephen Tyring, both with the University of Texas Health Science Center in Houston, wrote in a commentary accompanying the publication of the two studies on ustekinumab.
In the first study, two-thirds of patients with moderate-to-severe psoriasis achieved at least a 75 percent improvement in their skin condition (PASI 75 response) after 12 weeks of following regimens of either 45 milligram doses or 90 milligram doses of ustekinumab. At 40 weeks, 63 percent of those patients on 45 milligram doses were at or above the 75 percent level of improvement; 67 percent of those on the 90 milligram regimen had reached that level.
After 40 weeks, about half the patients achieving the PASI 75 response were randomly selected to stay on maintenance levels of ustekinumab, while the other half stopped using the drug. Over a year, the group on the maintenance dose did much better in retaining their improved psoriasis condition.
"Our results suggest that ustekinumab could be an important therapeutic agent for treating patients with psoriasis... The high level of efficacy was generally maintained with dosing every 12 weeks, a schedule that could offer a novel level of convenience for patients and physicians," the report's authors concluded.
In the second study, researchers found that the higher 90 milligram doses of ustekinumab, when increased from once every 12 weeks to once every eight weeks, were effective at helping moderate-to-severe psoriasis patients who had only partially reached the desired 75 percent while taking lower or less frequent doses.
"Although treatment with ustekinumab every 12 weeks is effective for most patients with moderate-to-severe psoriasis, intensification of dosing to once every eight weeks with ustekinumab 90 milligram might be necessary to elicit a full response in patients who only partially respond to the initial regimen," the authors concluded.HealthDay
PhD Studentship in Psychology, University of Birmingham, UK
A qualitative study of British South Asian Carers’ views of their Children with Developmental DisabilitiesA collaborative studentship provided by Wolverhampton Primary Care Trust and the School of Psychology, University of Birmingham.Funding is available for a three-year PhD studentship from October 2008, for a largely qualitative research project which will involve close collaboration between the School of Psychology at the University of Birmingham and the Wolverhampton Primary Care Trust. The proposed research will seek to develop an understanding of the views of South Asian parents about their children, and about their developmental disabilities. A detailed, culturally-sensitive, and systematic account of these views will allow us to understand their role in shaping the care of children. The project will allow us to better understand parents access to, and interactions with, service systems. As a result, we will be able to help South Asian carers to use services more effectively, and for services to adapt more effectively to the needs of this client group.Research supervision will be provided by Dr John Rose and Dr Michael Larkin in the Clinical Psychology team. Dr Rose has a track record of conducting and supervising research in the field of developmental disability; Dr Larkin has a track record on conducting and supervising qualitative and phenomenological research in the area of culture and psychology. The successful candidate will join a 5* RAE-rated Psychology department with excellent facilities, established research groups, and substantial external funding. The School supports around 250 postgraduate students in professional training and research degrees.
The studentship requires an Honours degree in Psychology (2:1 or above); Enthusiasm for research, and commitment to producing and disseminating excellent qualitative research; Commitment to the wellbeing of people with learning disability, and their families; Good communication and organisational skills. Prior knowledge of qualitative or phenomenological psychology would be a considerable advantage, as would fluency in at least one South Asian language.The studentship will be at the basic UK research council rate (expected GBP 12,600 per annum) to provide support over the three-year period, and will cover tuition fees. The student may also be eligible to contribute to our paid Teaching Assistant programme.
Application
For more information, and informal discussion about the studentship, please contact Dr. John Rose (j.l.rose[ at ]bham.ac.uk) or Dr Michael Larkin (m.larkin[ at ]bham.ac.uk). To obtain the Schools Research Studies brochure and an application form, please contact Ms. Parveen Chahal (p.k.chahal[ at ]bham.ac.uk).
The closing date for applications is 30th June, 2008
PhD Studentship in Economics, City University London, UK
The Department of Economics at City University, London, is able to offer a three-year studentship to a candidate who wishes to read for a PhD in Economics starting October 2008. The studentship will consist of full remission of fees for three years plus a subsistence grant of £13,500 per year. In return the successful candidate will be expected to provide up to 50 hours per year of undergraduate class teaching and mark 50 undergraduate coursework scripts. Additional teaching and marking may be undertaken subject to approval of the student’s supervisory panel and will be paid at our normal rates.
The areas of interest to the Department are:
* Competition and regulation
* Development Economics
* Econometrics and economic theory
* Financial economics
* Health economics
* History and philosophy of economics
* Macroeconomics and international economics
For more information about current research activity in the Department,
please go to this page, and follow the links from http://www.city.ac.uk/economics/staff.html to individual staff web pages.
Applicants are advised to contact potential supervisors in their research area with their proposal before making a formal application.
Application procedure
Please follow the procedure indicated at this page, making clear that you wish to apply for the Departmental Studentship.Your proposal should follow the format described at here.
Applications for the studentship must be received by Friday 18 July 2008. In the event of any queries, please contact the Senior Tutor for Research, Professor Giulia Iori: g.iori[ at ]city.ac.uk
Deadline: 18 July 2008
PhD Positions in Mathematics and Numerics for Inverse Problems, University of Bergen, Norway
Research Fellow (PhD position) - Mathematics and Numerics for Inverse Problems
At the Department of Mathematics/CIPR a 3-year position as Research Fellow (PhD position) is available within the area of Mathematics and Numerics for Inverse Problems. Work location will be at CIPR. The project, which is financed by the Norwegian Research Council and several energy companies, is collaboration between research groups at CIPR, University of Bergen and CMA, University of Oslo (http://www.cma.uio.no ). The candidate will participate in an international network of researchers focusing on development of novel computational methods for solving inverse problems. Such methods are very important within, for example, modelling and remote monitoring of flows in petroleum reservoirs and modelling and remote monitoring of geological storage of CO2. The candidate will focus in particular on development and analysis of inversion methods based on more than one data type. We seek a candidate with background from at least one of the fields: applied/numerical mathematics, physics, or mathematical statistics.The research fellow must take part in the Universitys approved PhD programme leading to the degree within a time limit of 3 years. Application for admission to the PhD programme, including a project plan outline for the training module, will be worked out in collaboration with the research group in question.
The fellowship period may be reduced if the successful applicant has held previous employment as research fellow.Applicants must have achieved a masters degree in mathematics, physics or related areas, or have submitted their master thesis for assessment by the application deadline. It is a prerequisite, however, that the formal admission requirements for the PhD programme are met before appointment can be made.Starting salaries at salary level 43 (code 1017) on the government salary scale; currently corresponding to NOK 325,800 gross p.a.; following ordinary meriting regulations (range 43/47).ApplicationFor further information about the positions please contact Adjunct Professor Trond Mannseth, phone 55583675, e-mail trond.
mannseth[ at ]cipr.uib.no, or Adjunct Professor Sigurd Aanonsen, phone 55583287, e-mail sigurd.aanonsen[ at ]cipr.uib.noWomen in particular are invited to apply. If, in the opinion of the evaluation committee, several applicants have approximately equivalent qualifications, the rules on equal opportunities laid down in the Personnel Regulations for Academic Positions will be applied.
State employment shall reflect the multiplicity of the population at large to the highest possible degree. The University of Bergen has therefore adopted a personnel policy objective to ensure that we achieve a balanced age and sex composition and the recruitment of persons of various ethnic backgrounds. Persons of different ethnic backgrounds are therefore encouraged to apply for the position.The University of Bergen applies the principles of public openness when recruiting staff to scientific positions.The successful applicant must comply with the guidelines that apply to the position at any time.The electronic application must include a complete overview of education and professional activities (CV), scanned copies of diplomas and transcripts, publications, a list of publications and other scientific works, and contact details of two or three referees, and should be sent to post[ at ]cipr.uib.noClosing date for applications: 20 June 2008Quote reference number: Inversjon 08/6803
PhD Fellowship on Formal Methods and Computer Algebra, Johannes Kepler University, Austria
Research Institute for Symbolic Computation (RISC) Johannes Kepler University, Linz, AustriaIn the frame of a newly established doctoral program for computational mathematics, we can offer to students with a master degree in computer science or mathematics a three years PhD fellowship (October 2008- September 2011) in the area of “formal methods and computer algebra”, seehttp://www.dk-compmath.jku.at/projects/schreiner/
Net salary (after taxes) is about 17700 € per year
For more details and applications forms see: http://www.dk-compmath.jku.at/application
Deadline for application: June 30, 2008
Further questions can be directly addressed to: Wolfgang.Schreiner[ at ]risc.uni-linz.ac.at
Friday, June 06, 2008
Dermatologists Release Psoriasis Care Guidelines
Biologics -- given by injection or infusion -- are systemic medications that pinpoint immune responses involved with psoriasis and psoriatic arthritis.
About 6 million to 7 million Americans have psoriasis, and between 300,000 and 750,000 have psoriatic arthritis. The new guidelines, based on an analysis of scientific studies of the conditions, were published in the May issue of the Journal of the American Academy of Dermatology.
"As a result of the impartial analysis of the most current research, physicians now have evidence-based guidelines which will help enhance the quality of care for patients and ultimately their safety," ADA President Dr. C. William Hanke said in a prepared statement.
"The guidelines for psoriasis and psoriatic arthritis, which focus on the use of biologics, are the first phase of the academy's efforts. The academy is currently working on the second phase of these guidelines, which will provide evidence-based advice for the management of psoriasis with topical therapies, ultraviolet light therapy, and systemic non-biologic therapies for psoriasis."
The new guidelines advise that topical treatments are appropriate for patients who are good candidates for localized therapy. But, in many cases, topical treatments should not be used exclusively to treat psoriasis if patients would benefit from a combination of systemic and/or phototherapy treatments.
Currently, five biologics are approved by the U.S. Food and Drug Administration for treatment of psoriasis, and three of those five are approved for psoriatic arthritis.
Because biologics target the immune system, it's important to use all approaches, including vaccination, to prevent infection, the guidelines state. However, once biologic therapy has started, patients should avoid vaccinations with live vaccines and consult their dermatologist before receiving vaccination of any kind.
Patients undergoing biologic therapy need to have periodic re-evaluations by their dermatologist to check for the development of new symptoms, including infections and potential cancers.
"Regardless of the therapy that is used to treat psoriasis or psoriatic arthritis, patients need to be in constant contact with their dermatologists to report any unusual side effects or fluctuations in their condition that may require an adjustment in their medications or indicate the onset of psoriatic arthritis or another secondary medical condition," Hanke said. "These guidelines should help further the understanding of the current psoriasis therapies and help enhance the overall health and quality of life of patients.
PhD Positions in the Life Sciences, ETH Zurich and University of Zurich, Switzerland
The Life Science Zurich Graduate School houses several Ph.D. programs that cover distinct areas of the life sciences. Each program offers research and education opportunities in a stimulating international environment for ambitious students who wish to work towards a Ph.D. degree. Accepted students perform their research project in one of the participating research groups of their favorite program, according to their scientific interest. Advanced teaching and training courses are offered throughout the curriculum. The program language is English throughout.
Applicants must hold or anticipate receiving a Masters degree or equivalent from a university in a relevant field before starting the Ph.D. program. Applicants accepted for the program will have to register with either the University of Zurich or ETH Zurich, depending on the affiliation of their future research group.
Application deadlines: July 1st and December 1st
Ph.D. studies usually last 3-4 years
Our web pages provide detailed information for submission of application. Please refer to the guidelines as we only take into consideration applications received in the required format.
Submission of application only via Internet at:
http://www.lifescience-graduateschool.ch/index.php?id=108
PhD and PostDoc Positions in Short Range Sensing, Localization and Wireless Communication, Norway
Postdoctoral Position and Graduate Research Opportunities in Biomedical Informatics, Columbia University, USA
Graduate research opportunities in clinical research informatics or team science
How to apply:
Interested applicants should submit a letter of interest, CV, and name and contact information of three references by mail to
Chunhua Weng, PhD
Assistant Professor
Department of Biomedical Informatics
Columbia University
622 West 168th Street , VC-5, New York , NY 10032 , USA
or by e-mail to cw2384@columbia.edu with subject line “Postdoctoral application.”
Via: official announcement
PhD Studentships in Statistics, University of Bristol, UK
Posts
